i-KAIST Lab Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
54,750
58,741
39,160
29,861
29,623
10,164
Cost of Goods Sold (COGS) incl. D&A
45,974
44,844
34,578
28,112
28,520
9,699
Gross Income
8,776
13,897
4,582
1,749
1,103
464
SG&A Expense
19,485
11,663
10,377
7,319
5,635
9,946
EBIT
10,766
1,858
6,352
-
4,742
9,661
Unusual Expense
2,291
93
1,212
-
541
6,522
Non Operating Income/Expense
145
307
495
3,602
570
659
Interest Expense
1,765
1,485
1,368
1,260
1,023
21,555
Pretax Income
14,443
1,221
8,813
10,223
5,680
23,921
Income Tax
898
3
4
2,559
-
-
Equity in Affiliates
71
80
25
-
-
-
Consolidated Net Income
13,473
1,144
8,785
12,783
5,680
23,921
Net Income
13,473
1,144
8,785
12,783
5,677
23,921
Net Income After Extraordinaries
13,473
1,144
8,785
8,117
5,677
23,486
Net Income Available to Common
13,473
1,144
8,785
17,449
5,677
24,355
EPS (Basic)
1,145.00
97.00
746.00
1,260.00
315.00
780
Basic Shares Outstanding
12
12
12
14
18
31
EPS (Diluted)
1,144.82
97.20
746.42
1,260.09
315.01
779.99
Diluted Shares Outstanding
12
12
12
14
18
31
EBITDA
8,291
3,493
4,580
-
4,386
9,025
Other Operating Expense
58
377
557
-
210
179
Non-Operating Interest Income
525
633
614
208
57
111
Minority Interest Expense
-
-
-
-
3
-

About i-KAIST Lab Co.

View Profile
Address
27/F, Songdo Technopark IT Center
Inchon IN 21984
Korea, Republic Of
Employees -
Website http://www.gsinstrument.com
Updated 07/08/2019
POLUS BioPharm, Inc. engages in the manufacture and sale of electrical measuring, testing and analyzing instruments. Its main products include test and measuring instruments and telecommunication system. The test and measuring instruments consist of analyzer, analog oscilloscope, digital storage oscilloscope, generator, meter, counter, and power supply.